Dalcetrapib: JTT 705; JTT-705; R 1658; R1658; RG1658; RO 4607381; RO4607381

By  

Drugs in R&D, Vol. 10, Iss. 1, 2010-05 ,pp. : 33-36

Adis International

Access to resources Recommend Favorite

Effect of JTT-705 on cholesteryl ester transfer protein and plasma lipid levels in normolipidemic animals

By Okamoto H.   Iwamoto Y.   Maki M.   Sotani T.   Yonemori F.   Wakitani K.  

European Journal of Pharmacology, Vol. 466, Iss. 1, 2003-04 ,pp. : 147-154

Elsevier

Access to resources Recommend Favorite

On- and Off-Target Pharmacology of Torcetrapib: Current Understanding and Implications for the Structure Activity Relationships (SAR), Discovery and Development of Cholesteryl Ester-Transfer Protein (CETP) Inhibitors

By Johns Douglas G.   Duffy Joseph   Fisher Timothy   Hubbard Brian K.   Forrest Michael J.  

Drugs, Vol. 72, Iss. 4, 2012-03 ,pp. : 491-507

Adis International

Access to resources Recommend Favorite

The DEFINE study: a bright future for CETP inhibitors?

By Katsiki Niki   Athyros Vasilios G   Mikhailidis Dimitri P  

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 3, 2011-03 ,pp. : 311-314

Informa Healthcare

Access to resources Recommend Favorite

The withdrawal of torcetrapib from drug development: implications for the future of drugs that alter HDL metabolism

By Howes Laurence G   Kostner Karam  

Expert Opinion on Investigational Drugs, Vol. 16, Iss. 10, 2007-10 ,pp. : 1509-1516

Informa Healthcare

Access to resources Recommend Favorite